Max Planck researchers have analyzed DNA from 728 sediment samples from Denisova Cave. Their study provides unprecedented detail about the occupation of the site by both archaic and modern humans over 300,000 years. The researchers ...
Jun 23, 2021
0
5
Global land-use changes—including forest fragmentation, agricultural expansion and concentrated livestock production—are creating "hot spots" favorable for bats that carry coronaviruses and where conditions are ripe for ...
Jun 2, 2021
0
3
Urinalysis has long been a staple of physical exams to detect and manage a number of diseases and disorders, but not cancer. What if it were that easy, though, and cancer was detected in its very earliest stages when the ...
Feb 18, 2021
0
177
Alzheimer's disease is the most common dementia worldwide and it is characterized by learning impairment, memory loss, disorientation and anxiety, among other behavioral and psychological symptoms. Since Alois Alzheimer described ...
Nov 16, 2020
0
13
A new study suggests that it is possible to design drugs that can target a type of shape-shifting protein involved in Alzheimer's disease, which was previously thought to be undruggable.
Nov 4, 2020
0
30
Dr. Gerd Mittelstädt from Te Herenga Waka-Victoria University of Wellington's Ferrier Research Institute is contributing to the search for a COVID-19 vaccine by finding a rapid way to produce the proteins needed to assess ...
Sep 28, 2020
0
1
A research collaboration between Monash University and Lava Therapeutics details a novel immune-oncology approach for the potential treatment of cancer. Instrumental to the study was co-first author Dr. Roeland Lameris from ...
Sep 14, 2020
0
248
In a recent study of genes involved in brain functioning, their previously unknown features have been uncovered by bioinformaticians from the Moscow Institute of Physics and Technology and the Institute of Mathematical Problems ...
Jul 9, 2020
0
0
In a study that could give a literal meaning to the phrase "food for thought," researchers from Kyushu University in Japan have reported that a protein fragment that makes its way into the brain after being ingested can reduce ...
Jun 22, 2020
0
135
Argenx, a Belgian drug maker, recently announced a successful phase 3 ADAPT trial of its experimental drug, efgartigimod. The company plans to seek U.S. approval of the drug by the end of year as a potential new treatment ...
May 29, 2020
0
12
